Published in Behav Neural Biol on September 01, 1994
Scale for the measurement of attitudes toward physicians and primary medical care. Med Care (1970) 4.54
Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health (1976) 4.38
The AAFP-UNC study of the organization, utilization, and assessment of primary medical care. Am J Public Health (1973) 3.57
Scale for the measurement of "satisfaction" with medical care: modifications in content, format and scoring. Med Care (1974) 2.39
Doctor-patient communication and outcomes among diabetic patients. J Community Health (1975) 2.25
Satisfaction with medical care in a low income population. J Chronic Dis (1971) 2.22
Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol (1977) 2.10
Medication use and misuse: physician-patient discrepancies. J Chronic Dis (1975) 2.07
Correlates of satisfaction and dissatisfaction with medical care: a community perspective. Med Care (1975) 1.79
A method for measuring physicians' awareness of patients' concerns. HSMHA Health Rep (1971) 1.76
Determinants of physician utilization: approach to a service-oriented classification of symptoms. Med Care (1972) 1.72
Social support and health. Med Care (1977) 1.62
Psychosocial factors in essential hypertension. Recent epidemiologic and animal experimental evidence. Am J Epidemiol (1969) 1.61
Serum uric acid. Its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med (1973) 1.53
Cerebrovascular disease in the bi-racial population of Evans County, Georgia. Stroke (1974) 1.50
Social disorganization and stroke mortality in the black population of North Carolina. Am J Epidemiol (1971) 1.42
Influence of race, sex and weight on blood pressure behavior in young adults. Am J Cardiol (1975) 1.38
The endothelium-dependent vasodilator effect of acetylcholine: characterization of the endothelial relaxing factor with inhibitors of arachidonic acid metabolism. Eur J Pharmacol (1984) 1.37
A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry (2000) 1.28
Black-white differences in serum lipids and lipoproteins in Evans County. Prev Med (1975) 1.26
The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology (1991) 1.25
Effectiveness of physician-mother interactions during infancy. Pediatrics (1977) 1.24
Removal of the membrane-anchoring domain of epidermal growth factor leads to intracrine signaling and disruption of mammary epithelial cell organization. J Cell Biol (1998) 1.22
Influence of angiotensin, vasopressin or changes in flow rate on vasoconstriction, changes in volume and [3H]-noradrenaline release following postganglionic sympathetic nerve stimulation in the isolated cat spleen. Br J Pharmacol Chemother (1966) 1.20
Rats with fimbria-fornix lesions display a place response in a swimming pool: a dissociation between getting there and knowing where. J Neurosci (1995) 1.18
Synthesis and release of prostaglandins by rat brain synaptosomal fractions. J Neurochem (1976) 1.17
Weight and weight history in relation to cerebrovascular and ischemic heart disease. Arch Intern Med (1971) 1.17
Influence of isoproterenol, hydralazine and phentolamine on the renin activity of plasma and renal cortex of rats. Eur J Pharmacol (1970) 1.14
The importance of endogenous prostaglandins other than prostacyclin, for the modulation of contractility of some rabbit blood vessels. Br J Pharmacol (1984) 1.14
Cognitive performances and locomotor activity following dentate granule cell damage in rats: role of lesion extent and type of memory tested. Neurobiol Learn Mem (2001) 1.13
Attributable risk, population attributable risk, and population attributable fraction of death associated with hypertension in a biracial population. Circulation (1975) 1.12
Practice characteristics and quality of primary medical care: the doctor-patient relationship. Med Care (1975) 1.09
Physician management in primary care. Am J Public Health (1976) 1.09
Family aggregation of blood pressure in Evans County, Georgia. Arch Intern Med (1971) 1.08
The endothelium-dependent relaxation of rabbit aorta: effects of antioxidants and hydroxylated eicosatetraenoic acids. Br J Pharmacol (1984) 1.05
Primary medical care evaluation. The AAFP-UNC collaborative study. JAMA (1975) 1.04
Cerebrovascular disease in the biracial population of Evans County, Georgia. Arch Intern Med (1971) 1.03
Role inconsistency and health status. Soc Sci Med (1972) 1.03
Endothelium-dependent vasodilation by melittin: are lipoxygenase products involved? Am J Physiol (1985) 1.02
Endogenous adenosine as a modulator of hippocampal acetylcholine release. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.01
Summary of major findings of the Evans County cardiovascular studies. Arch Intern Med (1971) 1.01
Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline. Br J Pharmacol (1987) 1.01
Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.00
Spatial memory, habituation, and reactions to spatial and nonspatial changes in rats with selective lesions of the hippocampus, the entorhinal cortex or the subiculum. Behav Brain Res (1998) 1.00
Influence of life events and family routines on childhood respiratory tract illness. Pediatrics (1977) 0.99
Geographic differences in mortality from stroke in North Caroline. 1. Analysis of death certificates. Stroke (1976) 0.98
Immunohistochemical and neurochemical correlates of learning deficits in aged rats. Neuroscience (2000) 0.97
The role of endothelial and non-endothelial prostaglandins in the relaxation of isolated blood vessels of the rabbit induced by acetylcholine and bradykinin. Br J Pharmacol (1986) 0.97
Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats. Eur J Pharmacol (1972) 0.96
The mechanism of the drinking response to some hypotensive drugs: activation of the renin-angiotensin system by direct or reflex-mediated stimulation of -receptors. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.96
Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.95
Release of prostaglandins from isolated cat spleen by angiotensin and vasopressin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.95
Effect of prostaglandins D2, E2 and F2alpha on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol (1981) 0.94
Effects of intracerebroventricular administration of prostaglandin D2 on behaviour, blood pressure and body temperature as compared to prostaglandins E2 and F2 alpha. Psychopharmacology (Berl) (1983) 0.94
Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-butyrate. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.94
Presynaptic modulation of acetylcholine, noradrenaline, and serotonin release in the hippocampus of aged rats with various levels of memory impairments. Brain Res Bull (2003) 0.93
The incidence study--study design and methods. Arch Intern Med (1971) 0.92
Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology (1985) 0.91
Are cerebral prostanoids of astroglial origin? Studies on the prostanoid forming system in developing rat brain and primary cultures of rat astrocytes. Brain Res (1987) 0.91
Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.91
Enhancement of noradrenaline release by 12-O-tetradecanoyl phorbol-13-acetate, an activator of protein kinase C. Eur J Pharmacol (1986) 0.91
The fimbria-fornix/cingular bundle pathways: a review of neurochemical and behavioural approaches using lesions and transplantation techniques. Prog Neurobiol (1997) 0.90
Modulation of hippocampal serotonin (5-HT) release by endogenous adenosine. Eur J Pharmacol (1985) 0.90
Modulation of electrically evoked acetylcholine release in cultured rat septal neurones. J Neurochem (2001) 0.89
Selective activity enhancement and persistence in weanling rats after hippocampal X-irradiation in infancy: possible relevance for ADHD. Behav Neural Biol (1994) 0.89
Fimbria-fornix vs selective hippocampal lesions in rats: effects on locomotor activity and spatial learning and memory. Neurobiol Learn Mem (1998) 0.89
Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit. J Neurochem (1986) 0.89
Mice transgenic for exon 1 of Huntington's disease: properties of cholinergic and dopaminergic pre-synaptic function in the striatum. J Neurochem (2003) 0.89
[Inhibition by nephrectomy of drinking induced by hypotensive agents in rats]. Experientia (1971) 0.88
Regulation and glucocorticoid-independent induction of lipocortin I in cultured astrocytes. J Neurochem (1991) 0.88
Omega-conotoxin GVIA and pharmacological modulation of hippocampal noradrenaline release. Eur J Pharmacol (1988) 0.88
Value of high-resolution ultrasound in the differential diagnosis of scaphocephaly and occipital plagiocephaly. Int J Oral Maxillofac Surg (2012) 0.88
Reversible inactivation of the dorsal hippocampus by tetrodotoxin or lidocaine: a comparative study on cerebral functional activity and motor coordination in the rat. Neuroscience (2006) 0.87
Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma. Eur J Pharmacol (1981) 0.87
Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2. J Pharm Pharmacol (1983) 0.87
The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade. Br J Pharmacol (1987) 0.87
Protein kinase C and presynaptic modulation of acetylcholine release in rabbit hippocampus. Br J Pharmacol (1988) 0.86
Angina pectoris and the Rose questionnaire. Arch Intern Med (1971) 0.86
Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.86
Studies on the influence of thiamine on the synthesis of thiamine pyrophosphate-dependent enzymes in Saccharomyces cerevisiae. Biochim Biophys Acta (1970) 0.86
Effects of room and cage familiarity on locomotor activity measures in rats. Physiol Behav (2001) 0.86
Role of vasopressin in the ACTH response to isoprenaline. Eur J Pharmacol (1982) 0.86
"Short-stops" in rats with fimbria-fornix lesions: evidence for change in the mobility gradient. Hippocampus (1994) 0.86
[Effect of various blood pressure-lowering drugs on water uptake and output in rats]. Naunyn Schmiedebergs Arch Pharmakol (1970) 0.86
Blood fibrinolytic activity, social class and habitual physical activity--II. A study of black and white men in Southern Georgia. J Chronic Dis (1980) 0.85
Effect of pretreatment with 6-hydroxydopamine on the uptake and metabolism of catecholamines by the isolated perfused rat heart. Br J Pharmacol (1971) 0.85
[Coffee consumption, vascular diseases, and risk factors in the Evans County, Georgia study]. Z Ernahrungswiss Suppl (1972) 0.85
Comparison of the prostanoid synthesizing capacity in homogenates from primary neuronal and astroglial cell cultures. Biochem Pharmacol (1984) 0.84